0,1,2
6.6.1	  General guidelines recommendations for the treatment of prostate cancer,,
Recommendations  Strength rating,,
Low-risk disease,,
Watchful Waiting   (WW),Offer WW to patients with a life expectancy < 10 years.  Strong,
Active   surveillance (AS),Manage patients with a life expectancy > 10 years and low-risk   Strong  disease by AS.,
,Selection of patients,
,Patients with intraductal histology on biopsy should be excluded from   AS.,Strong
,Perform magnetic resonance imaging (MRI) before a confirmatory   biopsy if no MRI has been performed before the initial biopsy.,Strong
,Take both targeted biopsy (of any PI-RADS > 3 lesion) and systematic   biopsy if a confirmatory biopsy is performed.,Weak
,"If MRI is not available, per-protocol confirmatory prostate biopsies   should be performed.",Weak
,If a patient has had upfront MRI followed by systematic and targeted   biopsies there is no need for confirmatory biopsies.,Weak
